Guggenheim Capital’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-6,059
| Closed | -$221K | – | 2018 |
|
|
2022
Q4 | $221K | Buy |
+6,059
| New | +$221K | ﹤0.01% | 1771 |
|
|
2022
Q3 | – | Sell |
-5,710
| Closed | -$258K | – | 2047 |
|
|
2022
Q2 | $258K | Buy |
5,710
+519
| +10% | +$23.5K | ﹤0.01% | 1843 |
|
|
2022
Q1 | $395K | Sell |
5,191
-345
| -6% | -$26.3K | ﹤0.01% | 1766 |
|
|
2021
Q4 | $825K | Buy |
5,536
+1,948
| +54% | +$290K | ﹤0.01% | 1457 |
|
|
2021
Q3 | $523K | Buy |
3,588
+1,380
| +63% | +$201K | ﹤0.01% | 1724 |
|
|
2021
Q2 | $432K | Buy |
2,208
+262
| +13% | +$51.3K | ﹤0.01% | 1889 |
|
|
2021
Q1 | $352K | Sell |
1,946
-492
| -20% | -$89K | ﹤0.01% | 1890 |
|
|
2020
Q4 | $345K | Buy |
+2,438
| New | +$345K | ﹤0.01% | 1777 |
|